- Home
- Bharat Biotech
India approves Oxford’s, Bharat Biotech’s COVID-19 vaccines for restricted emergency use
Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials
Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin
Covaxin can work against mutated Covid-19 virus, says Bharat Biotech Chairman
Bharat Biotech, Ocugen to co-develop Covaxin for US market
Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
How is govt preparing for COVID-19 vaccination in the country?
Free COVID-19 vaccine for all in Kerala: CM Vijayan
Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT
Will take COVID-19 vaccine; safety, efficacy not a concern: Kiran Mazumdar-Shaw
Over 60 foreign envoys visit leading pharma companies in Hyderabad
Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month
Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Bharat Biotech confirms volunteer was hospitalised during Covaxin vaccine trial, says illness unrelated
Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials
Bharat Biotech planning to launch Covid-19 vaccine ‘Covaxin’ in second quarter of 2021
Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23